Influenza A H1N1 HA Antibodies

Antibodies that detect Influenza A H1N1 HA can be used in several scientific applications, including ELISA, Western Blot, Immunocytochemistry, Immunohistochemistry and Flow Cytometry. Our Influenza A H1N1 HA polyclonal, monoclonal and recombinant monoclonal antibodies are developed... Antibodies that detect Influenza A H1N1 HA can be used in several scientific applications, including ELISA, Western Blot, Immunocytochemistry, Immunohistochemistry and Flow Cytometry. Our Influenza A H1N1 HA polyclonal, monoclonal and recombinant monoclonal antibodies are developed in Rabbit and Mouse. Find the... Antibodies that detect Influenza A H1N1 HA can be used in several scientific applications, including ELISA, Western Blot, Immunocytochemistry, Immunohistochemistry and Flow Cytometry. Our Influenza A H1N1 HA polyclonal, monoclonal and recombinant monoclonal antibodies are developed in Rabbit and Mouse. Find the Influenza A H1N1 HA antibody that fits your needs. Choose from 1 of 37 Influenza A H1N1 HA antibodies, which have been validated in experiments with 20 publications and 44 images featured in our data gallery.

Browse primary antibodies for WB, Flow, IHC, ICC/IF, ELISA, IP, and other applications. Antibodies with Advanced Verification data have been validated for specificity to ensure that the antibody binds to the... Antibodies that detect Influenza A H1N1 HA can be used in several scientific applications, including ELISA, Western Blot, Immunocytochemistry, Immunohistochemistry and Flow Cytometry. Our Influenza A H1N1 HA polyclonal, monoclonal and recombinant monoclonal antibodies are developed in Rabbit and Mouse. Find the Influenza A H1N1 HA antibody that fits your needs. Choose from 1 of 37 Influenza A H1N1 HA antibodies, which have been validated in experiments with 20 publications and 44 images featured in our data gallery.

Browse primary antibodies for WB, Flow, IHC, ICC/IF, ELISA, IP, and other applications. Antibodies with Advanced Verification data have been validated for specificity to ensure that the antibody binds to the antigen stated. If you cannot find the antibody you’re looking for, contact us today to develop custom antibodies for specific targets, species and applications.

Target Information

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA. In early 2009, a novel swine-origin influenza A (H1N1) virus was identified in specimens obtained from patients in Mexico and the United States. The virus spread quickly around the world and on June 11, 2009, the World Health Organization declared it a pandemic. Influenza A virus has one of sixteen possible Hemagglutinin (HA) surface proteins and one of nine possible Neuraminidase (NA) surface proteins. The Hemagglutinin protein facilitates viral attachment while Neuraminidase is involved in viral release. These proteins also elicit immune responses that prevent infection or independently reduce viral replication. The genetic make-up of this swine flu virus is unlike any other: it is an H1N1 strain that combines a triple assortment first identified in 1998 including human, swine, and avian influenza with two new pig H3N2 virus genes from Eurasia, themselves of recent human origin. The distinct antigenic properties of the new swine influenza virus compared with seasonal influenza A (H1N1) virus suggest that human immunity against new swine influenza virus is limited, although the age distribution of reported cases suggests some degree of protection in older age groups.